Antibody induction by influenza vaccines in the elderly: a review of the literature
- PMID: 2683459
- DOI: 10.1016/0264-410x(89)90150-3
Antibody induction by influenza vaccines in the elderly: a review of the literature
Abstract
Conflicting results have been reported concerning the association between high age and response to influenza vaccines. Some authors have found a reduced response in aged subjects, others have found no difference or even better results as compared with younger control subjects. Seventeen papers were selected from international literature published in the period 1968-1988 for a review of the anti-haemagglutinin-IgG sero-response following vaccination: among 30 cases in which vaccine components could be studied independently, ten revealed a better immune response in young subjects than in the elderly, four found more favourable results in the elderly, and 16 could not detect any significant between-group-differences, the latter most probably because of a high type-2-error. Nine of these 16 cases tended to favour young subjects. These results were relativated by the finding that each paper had at least one of three methodological limitations: (1) the failure to exclude subjects with illnesses or using drugs influencing the immune system, (2) the failure to exclude subjects with previous vaccinations against influenza, (3) the failure to exclude subjects with high prevaccination antibody titres. The direction of these biases is such that failure to address any one issue will lead to an underestimate of the response of aged subjects. In view of the failure to control these biases, it was not surprising that the papers reviewed presented a heterogeneous picture. Thus, the association between high age per se and response to influenza vaccines, if any, has not yet been established. Suggestions are made for future studies in which admission criteria should control health state and previous exposure to influenza antigens.
Similar articles
-
Influenza vaccines: the effect of vaccine dose on antibody response in primed populations during the ongoing interpandemic period. A review of the literature.Vaccine. 1993;11(9):892-908. doi: 10.1016/0264-410x(93)90375-8. Vaccine. 1993. PMID: 8212834 Review.
-
Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults.Vaccine. 1996 Oct;14(14):1331-9. doi: 10.1016/s0264-410x(96)00058-8. Vaccine. 1996. PMID: 9004442
-
Influenza vaccination in elderly people.Exp Gerontol. 1999 Jun;34(3):445-52. doi: 10.1016/s0531-5565(99)00007-8. Exp Gerontol. 1999. PMID: 10433399 Review.
-
A 21-winter seasons retrospective study of antibody response after influenza vaccination in elderly (60-85 years old) and very elderly (>85 years old) institutionalized subjects.Hum Vaccin Immunother. 2017 Nov 2;13(11):2659-2668. doi: 10.1080/21645515.2017.1373226. Epub 2017 Sep 18. Hum Vaccin Immunother. 2017. PMID: 28922621 Free PMC article.
-
[Specific immune response to vaccination with an inactivated flue vaccine depending on prevaccine status and age of the person vaccinated].Vopr Virusol. 2000 Mar-Apr;45(2):26-9. Vopr Virusol. 2000. PMID: 10765547 Russian.
Cited by
-
Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines.J Virol. 2007 Jan;81(1):215-28. doi: 10.1128/JVI.01957-06. Epub 2006 Oct 18. J Virol. 2007. PMID: 17050593 Free PMC article. Clinical Trial.
-
Pneumococcal and influenza vaccination: current situation and future prospects.Thorax. 2002 Oct;57 Suppl 2(Suppl 2):II24-II30. Thorax. 2002. PMID: 12364707 Free PMC article. Review. No abstract available.
-
Safety and immunogenicity of a subvirion inactivated influenza A/H5N1 vaccine with or without aluminum hydroxide among healthy elderly adults.Vaccine. 2009 Aug 13;27(37):5091-5. doi: 10.1016/j.vaccine.2009.06.057. Epub 2009 Jul 3. Vaccine. 2009. PMID: 19577636 Free PMC article. Clinical Trial.
-
A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control.Hum Vaccin Immunother. 2017 Jul 3;13(7):1640-1652. doi: 10.1080/21645515.2017.1313375. Epub 2017 May 22. Hum Vaccin Immunother. 2017. PMID: 28532276 Free PMC article. Review.
-
Vaccination in the elderly: an immunological perspective.Trends Immunol. 2009 Jul;30(7):351-9. doi: 10.1016/j.it.2009.05.002. Epub 2009 Jun 18. Trends Immunol. 2009. PMID: 19540808 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical